Fidelity Advisor Biotechnology Fund Quote

FBTTX Fund  USD 35.24  0.02  0.06%   

Performance

Solid

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Fidelity Advisor is trading at 35.24 as of the 16th of December 2025; that is 0.06 percent down since the beginning of the trading day. The fund's open price was 35.26. Fidelity Advisor has less than a 15 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 16th of November 2025 and ending today, the 16th of December 2025. Click here to learn more.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. More on Fidelity Advisor Biotechnology

Moving together with Fidelity Mutual Fund

  0.82FPURX Fidelity PuritanPairCorr
  0.64FRIMX Fidelity Income ReplPairCorr

Moving against Fidelity Mutual Fund

  0.84FSCHX Chemicals PortfolioPairCorr
  0.78FTF Franklin TempletonPairCorr
  0.52FARMX Strategic AdvisersPairCorr
  0.51FSCOX Fidelity InternationalPairCorr
  0.46FSAVX Automotive PortfolioPairCorr

Fidelity Mutual Fund Highlights

Thematic IdeaMonster Funds (View all Themes)
Fund ConcentrationFidelity Investments Funds, Large Funds, Health Funds, Monster Funds, Health, Fidelity Investments, Large, Health (View all Sectors)
Update Date31st of December 2025
Fidelity Advisor Biotechnology [FBTTX] is traded in USA and was established 16th of December 2025. Fidelity Advisor is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Fidelity Investments family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 2.85 B in assets under management (AUM) with no minimum investment requirementsFidelity Advisor Bio is currently producing year-to-date (YTD) return of 1.33% with the current yeild of 0.02%, while the total return for the last 3 years was 10.19%.
Check Fidelity Advisor Probability Of Bankruptcy

Instrument Allocation

Top Fidelity Advisor Biotechnology Mutual Fund Constituents

AGIOAgios PharmStockHealth Care
BMYBristol Myers SquibbStockHealth Care
EXELExelixisStockHealth Care
IONSIonis PharmaceuticalsStockHealth Care
BLUEBluebird BioStockHealth Care
AMGNAmgen IncStockHealth Care
BMRNBiomarin PharmaceuticalStockHealth Care
VRTXVertex PharmaceuticalsStockHealth Care
More Details

Fidelity Advisor Bio Risk Profiles

Fidelity Advisor Against Markets

Other Information on Investing in Fidelity Mutual Fund

Fidelity Advisor financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Advisor security.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.